In this issue:
Durvalumab for treatment of solid tumours in patients with HIV-1 infection
Raxibacumab can be co-administered with the anthrax vaccine without impacting immunogenicity
Reduced PCV dosing schedule shows non-inferiority in South African infants
ICI immunotherapy for cancer confers a survival benefit regardless of sex, age or ECOG PS
Ad26.RSV.preF respiratory syncytial virus vaccine candidate shows promise in phase 1 testing
Anti–IL-13 antibody reverses epithelialmesenchymal transition biomarkers in eosinophilic esophagitis
Patients with X-linked agammaglobulinemia have increased morbidity and mortality
Severe autoinflammatory manifestations and antibody deficiency due to novel PLCG2 mutations
Subcutaneous C1-inhibitor is safe and effective for geriatric patients with hereditary angioedema
The immunologic status of infants born to SARS-CoV-2–infected mothers in Wuhan, China
Please login below to download this issue (PDF)